Conv. Plasma
Nigella Sativa
Peg.. Lambda

All HCQ studies
Meta analysis
Home COVID-19 treatment researchHCQHCQ (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Case 81% Improvement Relative Risk HCQ for COVID-19  Bhattacharya et al.  Prophylaxis Is pre-exposure prophylaxis with HCQ beneficial for COVID-19? Retrospective 106 patients in India Fewer cases with HCQ (p=0.001) Bhattacharya et al., medRxix, June 2020 Favors HCQ Favors control

Pre exposure Hydroxychloroquine use is associated with reduced COVID19 risk in healthcare workers

Bhattacharya et al., medRxix, doi:10.1101/2020.06.09.20116806
Jun 2020  
  Source   PDF   All Studies   Meta AnalysisMeta
HCQ reduced cases from 38% to 7%. 106 people. No serious adverse effects.
risk of case, 80.7% lower, RR 0.19, p = 0.001, treatment 4 of 54 (7.4%), control 20 of 52 (38.5%), NNT 3.2.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Bhattacharya et al., 9 Jun 2020, retrospective, India, preprint, 7 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
The beneficial role of N-acetylcysteine as an adjunctive drug in treatment of COVID-19 patients in a tertiary care hospital in India: an observational study
Raja Bhattacharya, Maitry Mondal, Subhendu Bikash Naiya, Lamsaka Lyngdoh, Dr Rishav Mukherjee, Prabhat K Singh
International Journal of Research in Medical Sciences, doi:10.18203/2320-6012.ijrms20204010
Background: N-acetyl cysteine, a mucolytic agent, demonstrates free radical scavenging and anti-inflammatory properties, and prevents endothelial dysfunction by inhibition of NF-KB and formation of no adducts. This has a potential role to tackle cytokine storms, endothelial dysfunction and prothrombotic state observed in COVID-19 manifestations like ARDS and Multi organ dysfunction. Methods: Institution based descriptive cross sectional study, 164 patients from laboratory confirmed RT PCR positive COVID-19 patients, in the study period from 27 th May 2020 to 10 th August 2020, were assessed, in medical college Kolkata, a dedicated COVID-19 care facility. Results: It was observed that moderate-severe patients who received N-acetyl cysteine along with standard therapy had average hospital stay duration of 12 days, higher rate of discharge, average duration of oxygen therapy of 8 days, less number of deaths and reduced transfer to critical care facilities. Conclusions: N-acetyl cysteine can be considered as an adjunctive therapy with standard protocol driven care, due to its beneficial anti-inflammatory and free radical scavenging properties.
Aldini, Altomare, Baron, Vistoli, Carini et al., N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why, Free radical res
Andrews, Prasad, Quyyumi, N acetyl cysteine improves coronary and peripheral vascular function, J Am Coll Cardiol
Bhattacharya, Mondal, Naiya, Lyngdoh, Mukherjee et al., The beneficial role of N-acetylcysteine as an adjunctive drug in treatment of COVID-19 patients in a tertiary care hospital in India: an observational study, Int J Res Med Sci
Bikdeli, Madhavan, Jimenez, Church, Dreyfus et al., COVID-19 and thrombotic or thromboembolic disease:implications for prevention, antithrombotic therapy, and followup, JACC
Carsana, Sonzogni, Nasr, Rossi, Pellegrinelli et al., Pulmonary postmortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study, The Lancet Infectious disease
Ellul, Benjamin, Singh, Lant, Michael et al., Neurological associations of COVID-19, Lancet Neurol
Flora, Grassi, Carati, Attenuation of influenza-like symptomatology and improvement of cell mediated immunity with long term N acetyl cysteine treatment, Eur respirJ
Goodman, Brunton, Chabner, Knollmann, Goodman & Gilman's pharmacological basis of therapeutics
Hagiwara, Ishii, Kitamura, Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice, Am J Respir Crit Care Med
Hurst, Shaw, Lemaistre, Laboratory and clinical evaluation of the mucolytic properties of acetyl-cysteine, Am Rev Respir Dis
Jang, Kim, Lee, Kim, Moon et al., The tyrosine phosphatase, SHP-1, is involved in bronchial mucin production during oxidative stress, Biochem Biophys Res Commun
Mata, Sarrion, Armengot, Carda, Martinez, Respiratory syncytial virus inhibits cilia genesis in differentiated normal human bronchial epithelial cells: effectiveness of N acetyl cysteine, PLOS ONE
Miller, Rivero, Ziad, Smith, Elamin, Influence of nebulized unfractionated heparin and Nacetylcysteine in acute lung injury after smoke inhalation injury, J Burn Care Res
Mp, N-acetylcysteine as a potential treatment for COVID-19, Future Microbiol
Nishikawa, Kanki, Ogawa, Differential effects of N acetyl cysteine on nitroglycerin and nicorandil induced vasodilation in human coronary circulation, J Cardiovasc Pharmacol
Prescott, Donovan, Jarvie, Proudfoot, The Disposition And Kinetics of Intravenous N acetylcysteine in patients with Paracetamol overdose, Eur J chin pharmacol
Sagristá, García, De Madariaga, Mora, Antioxidant and pro-oxidant effect of the thiolic com-pounds N-acetyl-L-cysteine and glutathione against free radical-induced lipid peroxidation, Free Radic Res
Soltan -Sharifi, Mojtahedzadeh, Najafi, Rouini, Khajavi et al., Improvement by N acetyl cysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and antioxidant power: evidence for underlying toxicological mechanisms, Hum Exp Toxicol
Stamler, Slivika, Biological chemistry of thiols in the vasculature and in vascular related disease, Nur Rev
Wu, Wu, Liu, Yang, The SARS-CoV-2 outbreak: What we know, Int J Infect Dis
Zhou, Fu, Zheng, Wnag, Zhao et al., Pathogenic T cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients, Natl Sci Rev
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop